BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
-1.31%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$15.3B
AUM Growth
+$15.3B
(-13%)
Cap. Flow
-$285M
Cap. Flow
% of AUM
-1.86%
Top 10 Holdings %
Top 10 Hldgs %
84.69%
Holding
129
New
12
Increased
7
Reduced
17
Closed
13
Top Buys
| 1 |
Akero Therapeutics
AKRO
|
$76.6M |
| 2 |
Rhythm Pharmaceuticals
RYTM
|
$47.5M |
| 3 |
CINC
CinCor Pharma, Inc. Common Stock
CINC
|
$26.5M |
| 4 |
IDEAYA Biosciences
IDYA
|
$24.9M |
| 5 |
BCYC
Bicycle Therapeutics
BCYC
|
$19.6M |
Top Sells
| 1 |
argenx
ARGX
|
$296M |
| 2 |
Legend Biotech
LEGN
|
$47.1M |
| 3 |
Insmed
INSM
|
$46M |
| 4 |
Krystal Biotech
KRYS
|
$26.9M |
| 5 |
Pacific Biosciences
PACB
|
$25.1M |
Sector Composition
| 1 | Healthcare | 98.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
BioAtla
BCAB
$28.7M
| – | – |
-825,000
| Closed | -$2.35M |
|